Summary
Massive claims of drug-overpricing turn on expert evidence of aggregate “loss of value” to Medicaid and other third-party payors.
In re Zyprexa Products Liability Litigation
PDF, Size: 3,527 KB
See Also
Mass Drug Pricing Fraud Turns on Aggregate ‘Loss of Value’ Evidence
Massive claims of drug-overpricing turn on expert evidence of aggregate “loss of value” to Medicaid and other third-party payers.